Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117143) titled 'A Clinical Study Evaluating the Safety, Tolerability, Biodistribution, Radiodose Measurement, and Preliminary Diagnostic Efficacy of 68Ga-DOTA-CTC1 in Patients with Hepatocellular Carcinoma' on Jan. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital
Condition:
Hepatocellular Carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-31
Target Sample Size: Experimental group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=297584
Disc...